Here are five insights:
1. Dr. Krohn specializes in non-surgical management of knee osteoarthritis, fracture healing and complex metabolic bone diseases.
2. Previously, Dr. Krohn served as the senior medical advisor for Eli Lilly, a global pharmaceutical company, where he was responsible for the Forteo osteoporosis medical team.
3. Dr. Krohn as served as clinical research director at Pittsburgh-based Mercy Hospital and as rheumatology fellowship program director at Oregon Health and Sciences University in Portland.
4. Dr. Krohn underwent fellowship training in rheumatology at Bloomington-based Indiana University. He earned his medical degree and completed his residency at Creighton University School of Medicine in Omaha, Neb.
5. He is a member of the Orthopaedic Trauma Association, Orthopaedic Research Society, American College of Rheumatology and American Society of Bone and Mineral Research.
More articles on practice management:
OrthoConnecticut adds 3 orthopedic surgeons to team
Drs. Lindsey Valone, Lucy Morizio & more: 9 orthopedic surgeons making headlines
OrthoNY seeks approval for $5.6M ASC, projects $5.8M revenue in 1st year: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
